Emergent BioSolutions
EBS
#7565
Rank
ยฃ0.30 B
Marketcap
ยฃ5.93
Share price
-2.92%
Change (1 day)
45.08%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): ยฃ0.12 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are ยฃ0.75 Billion. In 2024 the company made an earning of -ยฃ53.41 Million, an increase over its 2023 earnings that were of -ยฃ0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.12 B-335.09%
2024 -ยฃ53.41 Million-88.82%
2023 -ยฃ0.48 Billion242.73%
2022 -ยฃ0.14 Billion-153.8%
2021 ยฃ0.25 B-20.43%
2020 ยฃ0.32 B278.02%
2019 ยฃ86.15 M27.11%
2018 ยฃ67.78 M-27.12%
2017 ยฃ93 M17.21%
2016 ยฃ79.35 M0.45%
2015 ยฃ78.99 M73.51%
2014 ยฃ45.53 M41.36%
2013 ยฃ32.2 M35.2%
2012 ยฃ23.82 M0.4%
2011 ยฃ23.72 M-56.46%
2010 ยฃ54.49 M76.73%
2009 ยฃ30.83 M32.94%
2008 ยฃ23.19 M-5.62%
2007 ยฃ24.57 M
2005 ยฃ35.58 M269.89%
2004 ยฃ9.62 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.56 B 6,065.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.65 B 13,465.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ7.34 B 5,886.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-ยฃ9.19 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ67.05 M-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.59 B 1,201.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel